CrypvuCrypto market view
Market data not licensed for redistribution.

Cellid

299660 ยท KOSDAQ ยท R&D in Natural Sciences & Engineering

Close
โ€“ Previous close pending (official data.go.kr feed not active yet) Live price โ†—

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)โ€“
PERโ€“
PBRโ€“
ROE %-51.0
Debt ratio % (liabilities / equity)80
Revenue TTM (KRW bn)10.4
Op. profit TTM (KRW bn)-10.3
Dividend yield %โ€“

Basis: market cap at โ€ฆ; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (separate). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

Other scheduled dates (routine, not risks) (1)
  • 2026-11-10 ยท Routine schedule: extraordinary shareholder meeting

See it in the full calendar โ†’

Annual results (KRW bn)

20212022202320242025
Revenue0.90.5โ€“4.28.8
Operating profit-13.0-14.9-12.2-12.0-11.3
Net income-13.1-22.9-11.6-12.3-12.1

Quarterly results (KRW bn, 3 months)

2025Q12025Q22025Q32025Q42026Q12026Q2
Revenue1.62.12.32.83.22.1
Operating profit-2.7-2.4-2.5-3.7-1.6-2.5
Net income-2.7-2.5-2.4-4.5-1.5-19.0

Largest shareholder

As of the 2025 annual report: ๊ฐ•์ฐฝ์œจ and related parties hold 11.46% of common shares.

Recent disclosures

DateFilingSummary
2026-10-29Securities registration / prospectus
[๊ธฐ์žฌ์ •์ •]์ฆ๊ถŒ๋ฐœํ–‰๊ฒฐ๊ณผ(์ž์œจ๊ณต์‹œ)
DART original
2026-10-29Securities registration / prospectus
[๊ธฐ์žฌ์ •์ •]์†Œ์•ก๊ณต๋ชจ์‹ค์ ๋ณด๊ณ ์„œ
DART original
2026-10-29Rights offering (paid-in capital increase)
[๊ธฐ์žฌ์ •์ •]์ฃผ์š”์‚ฌํ•ญ๋ณด๊ณ ์„œ(์œ ์ƒ์ฆ์ž๊ฒฐ์ •)
DART original
2026-10-28Litigation
์†Œ์†ก๋“ฑ์˜์ œ๊ธฐใ†์‹ ์ฒญ(๊ฒฝ์˜๊ถŒ๋ถ„์Ÿ์†Œ์†ก) (์‹ ์ฃผ๋ฐœํ–‰๊ธˆ์ง€๊ฐ€์ฒ˜๋ถ„)
DART original
2026-10-28Litigation
์ฃผ์š”์‚ฌํ•ญ๋ณด๊ณ ์„œ(์†Œ์†ก๋“ฑ์˜์ œ๊ธฐ)
DART original
2026-10-21Shareholder meeting
[๊ธฐ์žฌ์ •์ •]์ฃผ์ฃผ์ดํšŒ์†Œ์ง‘๊ฒฐ์˜ (์ž„์‹œ์ฃผ์ฃผ์ดํšŒ)
DART original
2026-10-21Shareholder meeting
์˜๊ฒฐ๊ถŒ๋Œ€๋ฆฌํ–‰์‚ฌ๊ถŒ์œ ์ฐธ๊ณ ์„œ๋ฅ˜
DART original
2026-10-21Shareholder meeting
์ฃผ์ฃผ์ดํšŒ์†Œ์ง‘๊ณต๊ณ 
DART original
2026-10-19Governance / misc. (routine)
[๊ธฐ์žฌ์ •์ •]์ฃผ์‹๋งค์ˆ˜์„ ํƒ๊ถŒ๋ถ€์—ฌ์—๊ด€ํ•œ์‹ ๊ณ 
DART original
2026-10-19Governance / misc. (routine)
[๊ธฐ์žฌ์ •์ •]์ฃผ์‹๋งค์ˆ˜์„ ํƒ๊ถŒ๋ถ€์—ฌ์—๊ด€ํ•œ์‹ ๊ณ 
DART original
2026-10-19Governance / misc. (routine)
[๊ธฐ์žฌ์ •์ •]์ฃผ์‹๋งค์ˆ˜์„ ํƒ๊ถŒ๋ถ€์—ฌ์—๊ด€ํ•œ์‹ ๊ณ 
DART original
2026-10-19Governance / misc. (routine)
[๊ธฐ์žฌ์ •์ •]์ฃผ์‹๋งค์ˆ˜์„ ํƒ๊ถŒ๋ถ€์—ฌ์—๊ด€ํ•œ์‹ ๊ณ 
DART original

Past material filings and price reaction (market-adjusted)

DateFiling typeOn the news (vs. market)Next day (vs. market)20 days (vs. market)
2026-09-22Rights offering (paid-in capital increase)+3.1%-13.0%โ€“
2026-09-21Share sale agreement entailing change of control+7.4%+21.1%โ€“
2026-08-14Litigation-1.4%-0.5%+35.9%
2026-08-05Litigation-2.4%+3.9%+42.1%
2026-06-26Clinical trial / regulatory approval-31.0%-7.0%-18.8%
2026-05-08Clinical trial / regulatory approval-4.8%-0.9%-4.3%
2026-03-05Other material event (investment-relevant)-0.1%-2.7%+1.9%
2026-03-05Revenue/profit change >=30% (15% large caps)-0.1%-2.7%+1.9%
2026-02-06Clinical trial / regulatory approval+6.6%-0.1%-27.0%
2026-01-16Other material event (investment-relevant)-1.7%-5.4%+6.4%
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer โ†’ Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view